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Human transthyretin has an intrinsic tendency to form amyloid fibrils and is
heavily implicated in senile systemic amyloidosis. Here, detailed neutron
structural studies of perdeuterated transthyretin are described. The analyses,
which fully exploit the enhanced visibility of isotopically replaced hydrogen
atoms, yield new information on the stability of the protein and the possible
mechanisms of amyloid formation. Residue Ser117 may play a pivotal role in
that a single water molecule is closely associated with the -hydrogen atoms in
one of the binding pockets, and could be important in determining which of the
two sites is available to the substrate. The hydrogen-bond network at the
monomer–monomer interface is more extensive than that at the dimer–dimer
interface. Additionally, the edge strands of the primary dimer are seen to be
favourable for continuation of the -sheet and the formation of an extended
cross- structure through sequential dimer couplings. It is argued that the
precursor to fibril formation is the dimeric form of the protein.
1. Introduction
Human transthyretin (TTR) is a 55 kDa homotetramer that
transports thyroxine and retinol-binding protein in the blood
and cerebrospinal fluid (Hamilton & Benson, 2001; Schreiber
et al., 1995). Wild-type TTR is inherently amyloidogenic and
can lead to senile systemic amyloidosis (SSA). SSA is the most
widespread form of TTR amyloid disease and is associated
with microscopic amyloid deposits of uncertain clinical
significance in many organs of all individuals who are over 80
years old, 25% of whom develop disease symptoms (Wester-
mark et al., 1990). Point mutations in the TTR gene often
result in early onset of disease, presumably due to destabili-
zation of the tetramer, rendering the protein prone to disso-
ciation and aggregation. This hereditary and often fatal form
of amyloidosis is also referred to as familial amyloid poly-
neuropathy (Plante´-Bordeneuve & Said, 2011). More than 100
TTR mutations have been described of which many are
pathogenic (Connors et al., 2003). A regularly updated list of
mutations together with their primary citations can be found
on the website http://amyloidosismutations.com/mut-attr.php.
A promising approach to the treatment of these diseases is
the stabilization of the native fold using drugs that inhibit
dissociation of the TTR tetramer and the subsequent aggre-
gation of the protein into its fibrillar form (Connelly et al.,
2010; Kolstoe et al., 2010; Sekijima et al., 2008). Several drug
candidates have been identified and tested and some have
been shown to suspend polyneuropathy by raising the kinetic
barrier of tetramer dissociation (Choi et al., 2010; Sekijima et
al., 2008). Other approaches have resulted in the development
of a potent and selective class of bivalent palindromic ligands
(Green et al., 2003; Kolstoe et al., 2010).
The stability of the homotetramer of wild-type TTR and the
changes associated with point mutations or ageing processes
are believed to be closely linked to the electrostatic and
hydrogen-bonding interactions present at the protein–protein
interface. Interestingly, wild-type TTR does not necessarily
degrade prior to aggregation and deposition in tissue (Ihse et
al., 2008; Pepys, 2009). It has been shown that amyloid fibrils
contain a high percentage of wild-type TTR for individuals
heterozygous for the Val30Met variant (Ihse et al., 2011;
Tsuchiya-Suzuki et al., 2011).
Neutron diffraction is a powerful tool for structural analysis
which strongly complements X-ray techniques because it
enables key details of hydration and protonation to be
revealed (Forsyth et al., 1989; Langan et al., 1992; Kovalevsky
et al., 2010; Tomanicek et al., 2010, 2011; Howard et al., 2011;
Kovalevsky et al., 2011; Weber et al., 2013; Cuypers, Mason et
al., 2013; Casadei et al., 2014; Langan et al., 2014). This occurs
because, in contrast to the situation with X-ray diffraction,
hydrogen and its isotope deuterium have scattering powers for
neutrons that are comparable with those for the other atoms
commonly found in biological macromolecules, and are
therefore more easily visible in neutron diffraction studies
(Blakeley, 2009). Perdeuteration of the sample, in which all
hydrogen atoms are replaced by deuterium, facilitates data
collection from smaller samples and those with larger unit cells
(Hazemann et al., 2005; Petit-Haertlein et al., 2009), and is
invaluable to other techniques used in structural biology and
soft matter research including small-angle neutron scattering
(Cuypers, Trubitsyna et al., 2013), neutron reflectometry
(Grage et al., 2011), fibre diffraction (Shotton et al., 1997;
Gardner et al., 2004; Nishiyama et al., 2010) and NMR (Varga
et al., 2007).
A recent review analysing the output of almost 200 X-ray
crystal structures of transthyretin, its mutants, complexes and
related proteins concludes that despite the abundance of data
available, no consistent and conclusive model for mutation-
induced structural changes or for the mechanism of amyloid
formation has been put forward (Palaninathan, 2012). The
neutron crystallographic analysis presented here sheds light
on a vitally important aspect – the role of hydrogen-atom
interactions in the stability of the structure. In addition to the
biological interest of these results, it is noted that the study
was carried out using two datasets recorded from completely
different neutron diffractometers at the Institut Laue-
Langevin (ILL). One was a quasi-Laue machine dedicated to
neutron protein crystallography, and the other was a mono-
chromatic instrument that is typically used for studies in
structural chemistry, small proteins, as well as fibre diffraction
studies of biological and synthetic polymers. Hence the results,
which are closely consistent, are of technical interest for an
understanding of the complementary scope of each approach.
2. Experimental procedures
2.1. Sample preparation
Human TTR was prepared and crystallized as described
previously (Haupt et al., 2011). This involved the use of a pET-
M11 bacterial expression vector with an N-terminal 6His tag
and a TEV cleavage site (EMBL Protein and Purification
Facility, Germany) with the TTR gene ligated via NcoI and
Acc65I restriction sites. Following transformation into
BL21(DE3) cells (Invitrogen), the cells were adapted to
perdeuterated ENFORS minimal medium and grown in a fed
batch fermentation process using U-D8-glycerol (99%
deuterium, Euriso-top) as the carbon source. Purification was
carried out using an Ni2+ column and subsequent gel filtration.
MALDI–TOF mass spectrometry showed deuteration of
100% of all non-exchangeable hydrogen atoms. Large single
crystals of 3 mm3 were grown using the vapour diffusion
method in sitting drops in 2.15M malonate buffer pD 6.0 and
23 mg ml1 protein concentration.
2.2. Quasi-Laue neutron data collection (LADI-III)
Details of the quasi-Laue neutron diffraction data collec-
tion have been reported previously (Haupt et al., 2011).
Neutron quasi-Laue diffraction data were collected at room
temperature on the LADI-III instrument (Blakeley et al.,
2010) installed on cold neutron guide H142 at the Institut
Laue-Langevin (ILL). Using a crystal of perdeuterated TTR
with volume of 3.4 mm3, diffraction data were collected to
2.0 A˚ resolution. As is typical for a Laue crystallography
experiment, the crystal was held stationary at a different ’
(vertical rotation axis) setting for each exposure. Initially, 12
contiguous images (’ = 7) were collected using an exposure
time of 8 h per image in order to collect the high-resolution
data, followed by a low-resolution pass of 11 contiguous
images (’ = 7) using an exposure time of 2 h per image.
Thus, the complete dataset comprised 23 images with an
average exposure time of 5.13 h per image. The neutron
diffraction images were processed using the LAUE suite
program LAUEGEN (Campbell, 1995; Helliwell et al., 1989),
which was modified to account for the cylindrical geometry of
the detector (Campbell et al., 1998). The program LSCALE
(Arzt, 1999) was used to determine the wavelength-normal-
ization curve using the intensities of symmetry-equivalent
reflections measured at different wavelengths and to apply
wavelength-normalization calculations to the observed data.
The data were then scaled and merged in SCALA (Evans,
2006). Relevant data collection statistics are summarized in
Table 1.
2.3. Thermal neutron data collection (D19)
Monochromatic data were recorded at room temperature
using the D19 diffractometer at the ILL. Data were recorded
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to a resolution of 2.3 A˚ using !-step scans of 0.07, to preset
monitor counts, with typical times per frame of 87 or 173 s. The
wavelength used was 2.42 A˚ produced using a graphite
monochromator. The /2 harmonic was reduced below 1%
using a graphite filter ahead of the sample position. The
detector was a large, curved multiwire proportional counter
having an angular coverage of 120 in the horizontal plane and
30 vertically. The data were processed using the ILL program
RETREAT (Wilkinson et al., 1988). The use of perdeuterated
protein effectively obviated the need for an absorption
correction. Data were merged using SCALA from the CCP4
suite (Winn et al., 2011). A summary of the experimental and
refinement statistics is given in Table 1.
2.4. X-ray data collection and structure refinement
X-ray diffraction data were recorded at room temperature
using beamline ID23-1 (Flot et al., 2010) at the European
Synchrotron Radiation Facility (ESRF), using a heavily
attenuated X-ray beam (0.74%) of wavelength 0.9791 A˚.
Integrated and scaled reflection intensities were obtained
usingMOSFLM (Battye et al., 2011; Leslie, 2006) and SCALA,
and converted to structure factors using TRUNCATE (Winn
et al., 2011). Radiation-damage effects were monitored using
the inter-frame merging R factors and B factors.
PDB code 3ipe was used as the starting model. All water
molecules and multiple conformations were removed and the
model was randomly perturbed to reduce model bias. Initially,
rigid-body refinement was then conducted using PHENIX
(Adams et al., 2010) to 1.95 A˚. Following this a series of
restrained refinements were conducted and the resulting A
weighted Fo  Fc electron-density map contoured to 3 was
used to model 148 solvent molecules and a number of multiple
conformations. Further rounds of restrained refinement were
conducted. The refinement converged with a final R factor of
15.2% and Rfree of 20.1%. Full refinement statistics are shown
research papers
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Table 1
Summary of data-collection and analysis statistics.
Laue neutron diffraction
Monochromatic neutron
diffraction X-ray diffraction
Data collection
Beamline LADI-III at ILL D19 at ILL ID23-1 at ESRF
Temperature (K) 293 293 293
Wavelength (A˚) 3.24–4.18 2.42 0.9791
Resolution (A˚) 43.68–2.00 (2.11–2.00) 52.21–2.30 (2.42–2.30) 52.28–1.85 (1.95–1.85)
No. reflections measured 69034 (6128) 40015 (4199) 76578 (10682)
No. unique reflections 13480 (1524) 11358 (1613) 21718 (3060)
Completeness (%) 78.3 (62.1) 99.3 (98.7) 99.4 (97.9)
No. of images 23 N/A 180
Oscillation angle () Step angle = 7 Scan step 0.07 0.5
Exposure time per image (s) 18470 (5.13 hours per image) 87 or 173 0.1 (beam attenuated to 0.74%)
Space group P21212 P21212 P21212
Unit-cell parameters (A˚)† a = 43.68, b = 86.26, c = 65.72 a = 43.68, b = 86.26, c = 65.72 a = 43.68, b = 86.26, c = 65.72
Rmerge 0.182 (0.337) 0.152 (0.645) 0.093 (0.420)
Rp.i.m. 0.078 (0.162) 0.096 (0.470) 0.057 (0.254)
Multiplicity 5.1 (4.0) 3.5 (2.6) 3.5 (3.5)
Mean I/(I) 7.3 (3.4) 7.7 (1.6) 7.4 (2.6)
Wilson B factor (A˚2) 15.7 14.9 19.8
Refinement Joint N–X Joint N–X X only
Resolution range (A˚) N: 36.38–2.00 (2.07–2.00) N: 52.28–2.30 (2.53–2.30) 43.13–1.95 (2.00–1.95)
X: 43.13–1.95 (2.00–1.95) X: 43.13–1.95 (2.05–1.95)
PDB code 4pvm 4pvn 4pvl
No. reflections N 13391 (923) 11395 (2630)
No. reflections X 18655 (1274) 18655 (2512) 18656 (1274)
Completeness (%) N 76.9 (60.0) 98.6 (98.0)
Completeness (%) X 99.4 (100.0) 99.4 (100.0) 99.5 (100.0)
Rwork N 0.209 (0.280) 0.209 (0.258)
Rwork X 0.153 (0.173) 0.156 (0.185) 0.152 (0.175)
Rfree N 0.271 (0.320) 0.262 (0.322)
Rfree X 0.203 (0.220) 0.185 (0.226) 0.201 (0.198)
No. protein atoms 3630 3680 1815 (no H or D)
No. main-chain amide-H atoms
with Hocc > 0.5
29 34 0
No. D2O, D—O, O-only molecules 36, 12, 41 30, 18, 36 148
R.m.s.d. bond length (A˚) 0.013 0.012 0.011
R.m.s.d. bond angles () 1.354 1.309 1.282
Average B factors (A˚2)
Main chain (A/B) 18.5/23.4 23.1/29.1 20.7/25.4
Side chain (A/B) 23.7/28.6 29.3/35.7 28.7/33.2
Solvent 26.8 46.4 40.9
Ramachandran statistics (%)
Favoured 98.3 98.3 97.8
Allowed 1.3 1.3 2.2
† X-ray cell dimensions were used for both neutron structures.
in Table 1 and the model has been deposited in the Protein
Data Bank (http://www.rcsb.org/pdb) under accession code
4pvl.
2.5. Joint neutron and X-ray structural refinement
The refined X-ray model of perdeuterated TTR to 1.95 A˚
resolution determined at room temperature was used as the
starting model for the joint X-ray and neutron refinement
using the phenix.refine program (Afonine et al., 2010) in the
PHENIX package (version 1.6.2). The model was first modi-
fied by removing all water molecules, resetting the atomic
displacement parameters (ADPs) of all atoms to 25 A˚2, and
randomly perturbing the atomic coordinates to reduce model
bias. Deuterium atoms were then added to the protein model
using the ReadySet option in PHENIX (Adams et al., 2010).
Initially rigid-body refinement was performed, followed by
several cycles of maximum-likelihood-based refinement of
individual coordinates, isotropic ADPs and atomic occu-
pancies of side-chain multiple conformations. Using the
modelling program Coot (Emsley et al., 2010), rotamer- and
torsion-angle adjustments were made manually throughout
the model according to positive nuclear scattering density in
both A-weighted 2Fo  Fc and Fo  Fc maps. The first nine
residues at the N-terminus, along with the last two residues at
the C-terminus of both chains A and B were found to be
disordered in the X-ray and neutron scattering density maps
and thus were not modelled, with the exception of Lys-9 which
could be modelled with the neutron data in chain B. Molecules
of D2O were added to the model according to positive neutron
scattering length density in A-weighted Fo  Fc maps, with
manual adjustment of all D2O molecules completed using
both A-weighted 2Fo  Fc and Fo  Fc maps. A total of 89
solvent molecules were included in the final round of refine-
ment using phenix.refine for the Laue dataset, and 84 in the
case of the monochromatic dataset. Based on the density
maps, these were modelled as full D2O molecules, D—O or
‘O-only’ (i.e exhibiting spherical density); a summary is given
in Table 1. A minimal r.m.s. level of 1.5 was used for the
attribution of water molecules. The same strategy was applied
for both quasi-Laue diffraction and monochromatic data. The
quasi-Laue neutron Rwork and Rfree values for the final model
were 20.9% and 27.1%, respectively, while the X-ray Rwork and
Rfree values were 15.3% and 20.3%, respectively. For mono-
chromatic neutron joint refinement the Rwork and Rfree values
for the final model were 20.9% and 26.2% for neutrons and
15.6% and 18.5% for X-rays, respectively. The final refinement
statistics from phenix.refine are summarized in Table 1.
MolProbity (Davis et al., 2007) was used to analyze the
stereochemistry of the final model (see Table 1). The models
and the diffraction data have been deposited in the Protein
Data Bank (http://www.rcsb.org/pdb) under accession codes
4pvm and 4pvn for the quasi-Laue and monochromatic
neutron models, respectively.
3. Results
3.1. Neutron crystal structures
As noted above, two independent neutron datasets were
obtained from the same crystal using two different diffract-
ometers at the ILL. The first was recorded using the quasi-
Laue diffractometer LADI-III (to a resolution of 2.0 A˚), and
the second was recorded using the monochromatic thermal
neutron diffractometer D19 (to a resolution of 2.3 A˚). Both
datasets were recorded at room temperature. An X-ray
dataset was subsequently collected to 1.95 A˚ resolution at
room temperature from a crystal originating from the same
crystallization well. The availability of both X-ray and neutron
diffraction data allowed joint refinements, increasing the data-
to-parameter ratio and reducing the influence of systematic
errors. A summary of the quasi-Laue neutron, monochromatic
neutron, and X-ray data collection statistics is given in Table 1,
along with details of each of the refinements carried out. A
comparison of the two neutron-derived structures showed
close agreement; a superposition was carried out using Coot
(Emsley et al., 2010) and the mean deviation was calculated to
be 0.13 A˚. It is interesting to note that while the study was
based on the use of perdeuterated protein (as assessed by
mass spectrometry), small amounts of exchange of D back to
H can be expected. This may happen during purification
(where hydrogenated reagents are usually used), and may not
fully reverse during crystallization in fully deuterated buffers.
Such back-exchange typically involved amide backbone
hydrogen atoms and was identified during the respective
structure refinements. The results described here for
perdeuterated wild-type TTR have been compared with the
crystallographic study of a truncated form of the hydro-
genated protein (Yokoyama et al., 2012). This study was
carried out to a resolution of 2 A˚ using the iBIX instrument at
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Figure 1
Front view along the bivalent hormone binding channel (a) and side view
perpendicular to the binding channel (b) of human transthyretin. Subunit
A (green) forms a continuous saddle-like curved -sheet with subunit B
(yellow). The concave shaped -sheet saddle constitutes the dimer–dimer
interface, leaving a spacious channel. Subunits A and A0 (cyan) constitute
the hormone binding site A, and subunits B and B0 (magenta) enclose
binding site B.
J-PARC (Tanaka et al., 2010). The comparison shows good
consistency between the two structures, and demonstrates the
major advantages arising from the use of perdeuterated
protein. As has been noted previously, the negative scattering
length of hydrogen for neutrons has a number of important
implications for neutron macromolecular crystallography. In
addition to hydrogen incoherent scattering and absorption
issues that affect data precision and data correction, the
character of neutron scattering length density maps obtained
are very different. If, as is often the case in protein crystal-
lography, high-resolution data are not obtained, cancellation
can occur between positive and negative regions of density
maps, and this may limit the clarity and interpretation of the
analysis. Additionally, given the significantly larger scattering
power of deuterium by comparison with its hydrogen isotope,
it is evident that deuterium atoms will be more easily identi-
fiable, even at lower resolutions. In the sections that follow, we
note points of comparison between this study and that of
Yokoyama et al. (2012).
3.2. Tertiary and quaternary structure
Native human TTR is known to be a homotetramer, or,
more precisely, a dimer of dimers (Fig. 1). The monomer
consists of two four-stranded -sheets, arranged in a sandwich-
like tertiary structure in which -strands HGAD are opposed
to -strands FEBC (Fig. 2). There is a short -strand, A*, that
is folded back relative to strand A via a -turn (i+5) and which
is involved in the dimer–dimer contact. The only helical part of
the secondary structure is an -helix located between strands
E and F, and also one solvent-exposed -turn (Thr60–Phe64)
that mediates a crystal contact.
The primary dimer relates the A-chain DAGH sheet to its
B-chain counterpart H0G0A0D0, forming what appears as an
almost continuous -sheet in which the monomer–monomer
interface is defined by six backbone hydrogen bonds on the
binding channel side of the sheet. Fig. 3(a) shows full details of
the close hydrogen bonding at this interface, as well as two
additional hydrogen bonds involving the side-chain hydroxyl
groups of residues Ser115/Awith Thr119/B, and Thr119/Awith
Ser115/B; in all cases the neutron density maps allow direct
visualization of the hydrogen atoms involved. On the other
side of the monomer ‘sandwich’, as shown in Fig. 3(b), the A
chain strands CBEF form a somewhat looser sheet-like
continuation with their B-chain counterparts, F0E0B0C0. Here
there are only four direct backbone hydrogen bonds joining
the F strands together. The amide group of Glu89/A, at the N-
terminus of strand F, interacts with the carbonyl group of
Val94/B in the centre of strand F, as does the amide group of
Glu89/B with the carbonyl group of Val94A. Between the
space spanned by these four residues, the neutron maps show
the location and orientation of three buried water molecules
bridging the ND–CO contacts between the F strands. The
central water molecule of the three, being in closer contact to
the side-chain hydroxyl group of Tyr116/B than it is to that of
Tyr116/A, highlights an important difference in the structure
of the two monomers making up the primary dimer (Fig. 4).
The dimer–dimer contact is mediated by only eight back-
bone hydrogen bonds. The same four atoms are implicated in
each monomer; Ala19/A CO interacts with the Tyr114/B0 ND,
and Gly22/A CO with Val122/A0 ND, etc. (Fig. 5). Several
residues are involved in hydrophobic contacts that further
stabilize the tetramer: Val20, Leu17, Val121, Leu110 and
Thr119.
The primary dimer, formed by monomers A and B,
constitutes the crystallographic asymmetric unit. Some struc-
tural differences between the two monomers are clear in
solvent-exposed loops (BC, CD, FG); these are likely to be
imposed by the crystal lattice and would not be relevant to
physiological conditions.
3.3. Buried water molecules
A total of 13 buried water molecules are found per dimer.
Five are located at the monomer–monomer interface. Four
research papers
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Figure 2
Schematic representation of the primary dimer. The dimer–dimer
interface is oriented towards the observer.
Figure 3
The monomer–monomer interface. (a) The continuous -sheet formed by
the monomers A (green) and B (yellow), as seen from the binding
channel. (b) The somewhat looser assembly on the solvent-exposed side
of the -sandwich. Three water molecules are wedged between strands F
and F0, preventing a smooth circular sequel of the CBEF sheet.
more are located in each of the monomers. One water mole-
cule is situated at the junction of strands A and D, making
hydrogen bonds to O/Leu12, O/Leu55 and D/Leu58. Several
amyloidogenic mutations are known to be associated with
these residues, with Leu55Pro being reported as the most
aggressive (Sousa et al., 2002).
A group of three water molecules is trapped between the
GH-loop, the residues preceding strand F, and the -helix. The
atoms involved in hydrogen bonding here are DG1/Thr75,
O/His88, ND1/His88, O/Pro113, DE1/Trp79, and O/Ser112
(Fig. 6). These interactions may be important given that this is
a highly conserved part of the structure, with data suggesting
that only one mutation, Ser112Ile, can be tolerated. This very
well ordered hydrogen-bond network is in agreement with the
structure described by Yokoyama et al. (2012).
Another isolated buried water molecule can be found
bridging the monomer–monomer interface between OG1/
Thr118 from one chain and DE2/His88 from the other chain.
The water molecule receives a hydrogen bond from NE2/
His88 and donates a hydrogen bond to OG1/THr 118; in turn
OG1 donates a hydrogen bond to the main-chain oxygen of
Ala108. There are no known mutations associated with these
residues. This feature is also noted in the structure reported by
Yokoyama et al. (2012).
Three more structured water molecules are found at the
monomer–monomer interface where the F-strands of chains
A and B join. The residues involved here are O/His90/A,
OH/Tyr116/A and D/Val94/B for the first water molecule,
OH/Tyr116/A, DH/Tyr116/B and O/Glu92/A for the central
water molecule, and OH/116Tyr/B, D/Val94/A and O/His90/B
for the third water molecule. Mutations relating to more or
less severe disease patterns are associated with all of these
residues.
3.4. Histidine protonation states
The four histidine residues in each of the A and B chains
show different protonation states. His31 is doubly protonated
in both A and B chains, as in the case in the corresponding
parts of the structure reported by Yokoyama et al. (2012). In
the case of His56, however, the neutron maps show double
protonation in the A-chain residue, and single protonation (on
ND1) in the B chain, whereas in the structure according to
Yokoyama et al. there is single (NE1) protonation in both
chains. For His88 there is full agreement between all struc-
tures, with single (ND1) protonation in both chains. Finally,
the His90 residue is protonated on ND1 in both chains in the
current structure, whereas Yokoyama and coworkers have this
residue protonated on NE1. The differences noted between
this structure and that of Yokoyama et al. may relate to the
different pD values associated with the respective studies
which were 6.0 and 7.4, respectively.
3.5. The thyroxin binding pocket
The intermolecular contacts formed by the dimer–dimer
interface result in the formation of a spacious channel (40 A˚
long) running along the twofold symmetry axis of the protein.
The channel is about 10 A˚ wide at the outer rim and narrows
in the centre to about 4 A˚. This narrowing is defined by the
alignment of Ser117A and Ser117B on the bottom of the cleft,
and by Ser117A0 and Ser117B0 on the top (Fig. 7), accom-
modating two separate binding sites. Small, though important,
differences between subunits A and B result in different
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Figure 5
Backbone hydrogen bonds stabilizing the dimer–dimer interaction. Four
out of the eight contacts are indicated with a dashed line (distances given
in A˚). The other four hydrogen bonds are the equivalent companions on
the reverse side of the protein and are not visible in the picture.
Figure 4
Hydrogen-bond networks in the region of the symmetry axis in the
primary dimer as revealed by the 2Fo  Fc neutron map. The central
water molecule is trapped between the Tyr116 -hydroxyl groups and the
Glu92 backbone carbonyl and amide groups. The water molecule
establishes a very close hydrogen bond with Tyr116 in the B-chain,
whereas the -hydroxyl group of the A chain tyrosine points away from
the water-oxygen atom to avoid steric hindrance.
geometries for the two hormone binding sites. Monomers A
and A0 form site A, and monomers B and B0 form site B, each
binding pocket being internally symmetric due to the twofold
symmetry axis that runs through the central channel of the
tetramer. The central part of this channel, close to Ser117, is
quite similar for both binding sites, although the protons of the
Ser117 hydroxyl groups have different orientations in the A
and B monomers (Fig. 7). In the A site, the -hydrogen atoms
chelate a structured water molecule, whereas in site B the -
hydrogen atoms are rotated by about 20 thus resulting in a
0.5 A˚ widening of the pocket (distance DG–DG0 4.1 A˚ in the
A site versus 4.7 A˚ in the B site); the neutron data show no
bound water at the B site. This important detail cannot be
derived from X-ray models with riding hydrogen atoms and is
consistent with the neutron data published by Yokoyama et al.
(2012). The two binding pockets show subtle structural
differences. The charged amino acids Lys15 and Glu54 that
define the position of thyroxine adopt very similar positions
and are well structured with low B-factors. However their
hydration states are different. The larger binding pocket B,
which has been postulated to have the higher binding affinity,
has a well defined water molecule bound to Lys15, whereas in
the narrower site A no hydration is noted.
4. Discussion
Despite its ability to form fibrils, transthyretin is a very stable
protein. It withstands temperature changes from 277 to 353 K
and pH variation between 5.5 and 12.0 without significant
damage (Lundberg et al., 2009). Studies concerning its
evolutionary development show that the central residues in
the binding channel have not changed in over 400 million
years (Prapunpoj & Leelawatwattana, 2009). The tertiary
structure shows an equally stable architecture that cannot
easily be disrupted. A comparison of 23 structures of wild-type
and mutant TTR showed no evidence for significant structural
changes between amyloidogenic, non-amyloidogenic or wild-
type TTR quarternary structure (Ho¨rnberg et al., 2000). In
fact, the authors of this study concluded that there was greater
structural variability amongst published X-ray structures of
wild-type TTRs originating from different research groups.
However, the fact that most of the known mutations in the
TTR gene have important implications for amyloidosis
suggests that there are aspects of TTR structure that are not
fully understood. We believe that the results described here,
particularly those relating to the hydration and protonation
states of the protein, may provide a fuller understanding of the
factors important in TTR stability and disassembly.
4.1. Ser117 – the pivotal point
A common characteristic of vertebrate TTR, with the
exception of fish, is the occurrence of the four Ser117 residues
in the centre of the molecule (Prapunpoj & Leelawatwattana,
2009). Ser117 has been reported as capable of subtle confor-
mational changes upon ligand binding (Morais-de-Sa´ et al.,
2004). This residue is located at the centre of the tetramer,
where the crystallographic (dimer–dimer interface)
and noncrystallographic (monomer–monomer interface)
symmetry axes intersect. A comparison of several X-ray
structures from the PDB shows considerable variation in the
assigned water structure in the binding channel – ranging from
zero to four water molecules situated between the central
serine residues, and it is therefore hard to be sure of the
significance of these observations. In this study, both of our
independent neutron datasets, which reveal water molecules
in greater detail than corresponding X-ray analyses, show the
presence of a single highly ordered water molecule, coordi-
nated by Ser117A and Ser117A0. This water molecule
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Figure 7
The highly symmetric centre of the homotetramer. The side chains of the
four Ser117 residues form a barrier between the two hormone binding
sites. The 2Fo  Fc neutron map (at 1.2 r.m.s.) shows clearly the different
orientation of the -deuterium atoms of serine residues in chains A and
B, and the presence of only one water molecule.
Figure 6
Cluster of three buried water molecules. The 2Fo  Fc neutron difference
map unambiguously detects the orientation of the water molecules and
the hydroxyl group of Thr75. The protonation state of His88 can be
readily identified.
mediates an important contact on one side of the dimer–dimer
interface (Fig. 7). We note this to be consistent with the
analysis of Yokoyama et al. (2012). The neutron data also show
the hydroxyl group orientation that stabilizes this water
interaction with good hydrogen bonding geometry.
4.2. Implications for the thyroxine binding cleft
The location of the Ser117A/Ser117A0 hydroxyl-water
interaction highlights the importance of subtle structural
differences between the A and B chains, as well as the fact that
the two thyroxine binding sites are not equivalent (see Fig. 7).
Early binding studies on human TTR with thyroxine
suggested a negative binding cooperativity, supported by a
decrease in the binding constant for the second thyroxine by a
factor of 100; the corresponding K1 and K2 dissociation
constants are approximately 10 nM and 1 mM, respectively
(Ferguson et al., 1975). Other monovalent binders such as
diflunisal and its analogues only occupy on average one
binding site (Adamski-Werner et al., 2004; Castan˜o et al.,
2012). However, it is hard to determine the ratio of unbound,
singly bound or doubly bound TTR tetramer (Wiseman et al.,
2005). Only bivalent compounds force the mutual occupation
of both binding sites in the protein, although they are spatially
demanding and imply a partial dissociation of the tetramer
before they can occupy the entire channel (Green et al., 2003).
Following this, other homo-bivalent inhibitors have been
designed to cross link the tetramers and thus speed up the
clearance of TTR from serum. Furthermore, under physio-
logical conditions, these constructs bind to wtTTR and show
an increased binding strength and stabilization of the tetramer
(Kolstoe et al., 2010).
This neutron analysis shows an asymmetry at the dimer–
dimer interface, leading to different opening angles of the
channels. In solution the protein is very likely to flex back and
forth, interchanging the two water molecules bound by the
Ser117 between the A–A0 site and the B–B0 site, thereby
slightly opening one or the other binding pockets. It has been
suggested that the slightly larger binding site is also the one
with the higher binding affinity (Neumann et al., 2001).
Immobilized in the crystal lattice, the existence of two
different ground states becomes apparent. Based on this
evidence, our structure supports the concept of two distinct
asymmetric binding sites having different affinities (Fig. 8).
Binding of the first ligand in the slightly bigger site will restrain
the protein’s flexibility, so that only the lower affinity binding
pocket is available. This assumption is supported by the
observation that the structure does not significantly change
upon ligand binding (Ho¨rnberg et al., 2000).
4.3. From the native fold to fibrils – a ‘dimer-only’ hypothesis
There are numerous theories concerning the fibril forma-
tion of transthyretin. One of the most popular is the hypoth-
esis that a complete degradation to the monomeric species has
to occur prior to aggregation (Lundberg et al., 2009; Wiseman
et al., 2005). Other publications suggest a mechanism via the
dimeric state of the protein (Serag et al., 2001). This model is
supported by the findings that there is a concentration of
amyloidogenic mutations in the edge strands C and D, whereas
there are few at the dimerization interfaces (Serpell et al.,
1996). A model for amyloid formation originating from the
tetrameric state has also been proposed (Eneqvist et al., 2000).
There is however broad consensus that the resulting amyloid
filament is a cross- structure having 4.7 A˚ inter-strand
spacing and 10.4 A˚ inter-sheet spacing (Blake & Serpell,
1996).
The idea that amyloid formation occurs from dissociated
monomers is at variance with the fact that even for mutated
transthyretin, harsh denaturing conditions (e.g. acidic pH close
to the pI) have to be deployed to disrupt the tetrameric
structure of the protein and generate fibrils in vitro. The fibrils
so formed are usually of poor quality and do not (as visualized
by electron microscopy) resemble fibrils from natural sources.
Furthermore, TTR disassembles into a dimer when exposed to
5% SDS, and the monomeric form is only obtained after
boiling the sample (Lundberg et al., 2009). A probe for the
existence of a monomeric species in vivo is the measurement
of subunit exchange under physiological conditions. By mixing
tagged wtTTR with non-tagged protein it has been shown that
subunit exchange can be observed after 40 h, and equilibrium
is reached after seven days (Schneider et al., 2001). However,
in nature the half-life of TTR in the blood is less than two days
(Ingenbleek & Young, 2002). This rather short biological half-
life ensures rapid disposal of denatured protein prone to form
fibrils, although some TTR clearly circumvents the pathway.
At the monomer–monomer interface, 12 inter-monomer
hydrogen bonds and about seven intermolecular hydrophobic
interactions (-stacking, hydrophobic side-chain arrange-
ments) were identified. The interactions on the dimer–dimer
interface are much weaker. For a surface that is more than
twice as big, only eight inter-dimer hydrogen bonds can be
allocated and few unspecific hydrophobic contacts. Thus, it is
very likely that the dimer–dimer dissociation event prevails
over monomer–monomer dissociation. Stereochemically, it is
also easy to see how the -sheet may be continued via a simple
dimerization of the edge-strands C and D (residues 45–58)
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Figure 8
Schematic illustration showing the proposed solution equilibrium
between the two putative conformations of the A and B binding pocket.
The entry to the binding pocket is wider for the B than for the A pocket
as a result of the water molecule complexed between the Ser117 residues
of monomers A and A0. This draws together the dimers, and thereby
narrows the A binding pocket.
with the corresponding strands from another dimer. Only
minor structural rearrangements are necessary to better
expose the amide and carbonyl groups to allow this associa-
tion with a binding partner. Once the first building block has
formed, it is only a matter of time and protein supply to sustain
fibril formation.
The slow build-up rate of fibrils due to the necessity of
nucleation presumably results in an exponential growth rate,
with a variable early age onset for mutated protein versus a
late onset for wtTTR.
5. Conclusions
Hydrogen accounts for almost 50% of all atoms present in a
protein. Neutron studies such as this one provide a unique
opportunity to reliably image these important atoms, and the
use of perdeuterated TTR has proved to be crucial. The data
presented here emphasize the importance of determining the
hydrogen-atom positions directly rather than assuming them
on the basis of chemical context. For example, the fact that the
hydrogen atom of the -hydroxyl group of Ser117A is rotated
by about 20 compared with the same residue on the B-chain
cannot be predicted on the basis of the very small confor-
mational change of the oxygen atom of the same group. This
subtle difference affects the quaternary protein structure at
the dimer–dimer interface, resulting in two hormone binding
sites with distinct binding constants.
The information on the location and orientation of buried
water molecules provides insight to the specific parts of TTR
that are believed to be important in stabilizing the structure of
the primary dimer. This is significant for developing a struc-
tural basis for understanding mutations of medical significance
and that are known to enhance fibril formation. The ordered
water structures around His88, Thr75, Trp79 and Ser112, are
therefore of particular significance, as is the protonation state
of His88. Neutron crystal structures of key mutants would
therefore be of clear benefit to this field.
The hydrogen-bonding network connections identified here
corroborate the hypothesis that a dimer is the principal
building block of TTR amyloid fibrils and that a complete
dissociation into monomers prior to fibril formation is not
likely. We are confident that these findings will be helpful for a
better understanding of the properties and dynamics of wild-
type transthyretin, and may lead to exploitable information to
counter amyloidosis.
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